Fed. Circ. Upholds Preliminary Ban on Roche's Mircera

Law360, New York (October 10, 2008, 12:00 AM EDT) -- An appeals court on Friday dashed Roche Holding AG’s hopes of bringing its generic anemia drug Mircera to market in the U.S. any time soon, affirming a lower court’s decision to grant Amgen Inc. a preliminary injunction.

In a per curiam decision that was not accompanied by an opinion, the U.S. Court of Appeals for the Federal Circuit affirmed the preliminary ban on Mircera handed down by the district court in February following a jury’s finding of infringement.

Roche had appealed the preliminary injunction with a...
To view the full article, register now.